MedTrace Logo

Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia

NCT02554318 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 147

Last updated 2022-06-21

Study results available
· View outcomes & findings →

Summary

Tuberculosis (TB) patients often have a lower body mass index (BMI) and experience wasting. Wasting reduces lean body mass and may cause physical function impairment. This study aimed to determine the efficacy of fermented soybeans (tempeh) as a food supplement on body weight and physical function changes among active pulmonary tuberculosis patients with standard therapy.

Conditions

  • Pulmonary Tuberculosis
  • Body Weight Changes
  • Motor Activity

Interventions

DRUG

Rifampicin

DRUG

Isoniazid

DRUG

Pyrazinamide

DRUG

Ethambutol

DIETARY_SUPPLEMENT

Fermented soybean

Sponsors & Collaborators

  • Indonesian Directorate General of Higher Education

    collaborator OTHER_GOV

  • University of Giessen

    lead OTHER

Principal Investigators

  • Michael B Krawinkel, Prof. Dr. · University of Giessen

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2015-02-28
Completion
2015-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02554318 on ClinicalTrials.gov